Dolutegravir + Emtricitabine + Tenofovir Alafenamide
Information about Dolutegravir + Emtricitabine + Tenofovir Alafenamide
Dolutegravir + emtricitabine + tenofovir alafenamide uses
Dolutegravir+Emtricitabine+Tenofovir Alafenamide is used in the treatment of HIV infection.
How dolutegravir + emtricitabine + tenofovir alafenamide works
This is a combination of three medicines: Dolutegravir, Emtricitabine and Tenofovir Alafenamide. It is an anti-HIV medication and works by preventing the action of reverse transcriptase enzyme. This enzyme is responsible for production of HIV.
Common side effects of dolutegravir + emtricitabine + tenofovir alafenamide
Insomnia (difficulty in sleeping), Headache, Nausea, Abdominal pain, Fatigue, Hepatitis (viral infection of liver), Myositis, Suicidal ideation, Renal impairment, Itching, Liver toxicity, Hypersensitivity, Worsening of hepatitis B (viral infection of liver), Immune reconstitution syndrome, Lactic acidosis, Hepatomegaly (enlarged liver), Anxiety